Literature DB >> 19211847

The role of adiponectin in inflammatory gastrointestinal diseases.

Andreas Schäffler1, Jürgen Schölmerich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19211847     DOI： 10.1136/gut.2008.159210

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  13 in total

1.  Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.

Authors:  Millie D Long; Wallace V Crandall; Ian H Leibowitz; Lynn Duffy; Fernando del Rosario; Sandra C Kim; Mark J Integlia; James Berman; John Grunow; Richard B Colletti; Bess T Schoen; Ashish S Patel; Howard Baron; Esther Israel; George Russell; Sabina Ali; Hans H Herfarth; Christopher Martin; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2010-12-17       Impact factor: 5.325

2.  Lesser omental panniculitis: a possible cause of acute abdomen.

Authors:  Yuichi Yasunaga; Kazunori Yanagawa; Sumio Kawata
Journal:  Clin J Gastroenterol       Date:  2019-08-22

Review 3.  Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.

Authors:  Siddharth Singh; Parambir S Dulai; Amir Zarrinpar; Sonia Ramamoorthy; William J Sandborn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-30       Impact factor: 46.802

4.  Does adiponectin upregulation attenuate the severity of acute pancreatitis in obesity?

Authors:  Hayder H Al-Azzawi; Kathryn M Ziegler; Deborah A Swartz-Basile; Sue Wang; Henry A Pitt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2011-06-10       Impact factor: 3.452

Review 5.  Value of adipokines in predicting the severity of acute pancreatitis: comprehensive review.

Authors:  Andrius Karpavicius; Zilvinas Dambrauskas; Audrius Sileikis; Dalius Vitkus; Kestutis Strupas
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

6.  Resistin is not an appropriate biochemical marker to predict severity of acute pancreatitis: a case-controlled study.

Authors:  Hamdi Al-Maramhy; Abdelrahman I Abdelrahman; Samer Sawalhi
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 7.  Contribution of immunomodulators to gastroesophageal reflux disease and its complications: stromal cells, interleukin 4, and adiponectin.

Authors:  Jing Li; Xiaoxin Luke Chen; Anisa Shaker; Tadayuki Oshima; Jing Shan; Hiroto Miwa; Cheng Feng; Jun Zhang
Journal:  Ann N Y Acad Sci       Date:  2016-07-21       Impact factor: 5.691

8.  Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease.

Authors:  V S Rodrigues; M Milanski; J J Fagundes; A S Torsoni; M L S Ayrizono; C E C Nunez; C B Dias; L R Meirelles; S Dalal; C S R Coy; L A Velloso; R F Leal
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

Review 9.  Unraveling the link between leptin, ghrelin and different types of colitis.

Authors:  Elisavet K Tiaka; Anastassios C Manolakis; Andreas N Kapsoritakis; Spyros P Potamianos
Journal:  Ann Gastroenterol       Date:  2011

10.  Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patients.

Authors:  Cilene Bicca Dias; Marciane Milanski; Mariana Portovedo; Vivian Horita; Maria de Lourdes Setsuko Ayrizono; Núria Planell; Cláudio Saddy Rodrigues Coy; Lício Augusto Velloso; Luciana Rodrigues Meirelles; Raquel Franco Leal
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.